222 related articles for article (PubMed ID: 17764209)
1. Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).
Matchar DB; Thakur ME; Grossman I; McCrory DC; Orlando LA; Steffens DC; Goldstein DB; Cline KE; Gray RN
Evid Rep Technol Assess (Full Rep); 2007 Jan; (146):1-77. PubMed ID: 17764209
[TBL] [Abstract][Full Text] [Related]
2. Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors.
Thakur M; Grossman I; McCrory DC; Orlando LA; Steffens DC; Cline KE; Gray RN; Farmer J; DeJesus G; O'Brien C; Samsa G; Goldstein DB; Matchar DB
Genet Med; 2007 Dec; 9(12):826-35. PubMed ID: 18091432
[TBL] [Abstract][Full Text] [Related]
3. Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Genet Med; 2007 Dec; 9(12):819-25. PubMed ID: 18091431
[TBL] [Abstract][Full Text] [Related]
4. Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine.
Scordo MG; Spina E; Dahl ML; Gatti G; Perucca E
Basic Clin Pharmacol Toxicol; 2005 Nov; 97(5):296-301. PubMed ID: 16236141
[TBL] [Abstract][Full Text] [Related]
5. CYP450 genotype and aggressive behavior on selective serotonin reuptake inhibitors.
Ekhart C; Matic M; Kant A; van Puijenbroek E; Schaik RV
Pharmacogenomics; 2017 May; 18(7):613-620. PubMed ID: 28470107
[TBL] [Abstract][Full Text] [Related]
6. Neither cytochrome P450 family genes nor neuroendocrine factors could independently predict the SSRIs treatment in the Chinese Han population.
Zhang X; Yu T; Li X; Li X; Huang X; Li X; He L; He G; Sun X
Pharmacopsychiatry; 2014 Mar; 47(2):60-6. PubMed ID: 24488700
[TBL] [Abstract][Full Text] [Related]
7. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes.
Berle JØ; Steen VM; Aamo TO; Breilid H; Zahlsen K; Spigset O
J Clin Psychiatry; 2004 Sep; 65(9):1228-34. PubMed ID: 15367050
[TBL] [Abstract][Full Text] [Related]
8. CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages.
Kirchheiner J; Brøsen K; Dahl ML; Gram LF; Kasper S; Roots I; Sjöqvist F; Spina E; Brockmöller J
Acta Psychiatr Scand; 2001 Sep; 104(3):173-92. PubMed ID: 11531654
[TBL] [Abstract][Full Text] [Related]
9. [Use of antidepressant drugs in schizophrenic patients with depression].
Micallef J; Fakra E; Blin O
Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
[TBL] [Abstract][Full Text] [Related]
10. Genetic screening for SSRI drug response among those with major depression: great promise and unseen perils.
Rasmussen-Torvik LJ; McAlpine DD
Depress Anxiety; 2007; 24(5):350-7. PubMed ID: 17096399
[TBL] [Abstract][Full Text] [Related]
11. Effect of Cytochrome P450 polymorphism on the action and metabolism of selective serotonin reuptake inhibitors.
Probst-Schendzielorz K; Viviani R; Stingl JC
Expert Opin Drug Metab Toxicol; 2015; 11(8):1219-32. PubMed ID: 26028357
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.
Arvanitidis K; Ragia G; Iordanidou M; Kyriaki S; Xanthi A; Tavridou A; Manolopoulos VG
Fundam Clin Pharmacol; 2007 Aug; 21(4):419-26. PubMed ID: 17635181
[TBL] [Abstract][Full Text] [Related]
13. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
de Leon J; Susce MT; Murray-Carmichael E
Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.
Bozina N; Granić P; Lalić Z; Tramisak I; Lovrić M; Stavljenić-Rukavina A
Croat Med J; 2003 Aug; 44(4):425-8. PubMed ID: 12950145
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
Gaikovitch EA; Cascorbi I; Mrozikiewicz PM; Brockmöller J; Frötschl R; Köpke K; Gerloff T; Chernov JN; Roots I
Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168
[TBL] [Abstract][Full Text] [Related]
16. AmpliChip CYP450 test: personalized medicine has arrived in psychiatry.
de Leon J
Expert Rev Mol Diagn; 2006 May; 6(3):277-86. PubMed ID: 16706732
[TBL] [Abstract][Full Text] [Related]
17. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
Jin Y; Desta Z; Stearns V; Ward B; Ho H; Lee KH; Skaar T; Storniolo AM; Li L; Araba A; Blanchard R; Nguyen A; Ullmer L; Hayden J; Lemler S; Weinshilboum RM; Rae JM; Hayes DF; Flockhart DA
J Natl Cancer Inst; 2005 Jan; 97(1):30-9. PubMed ID: 15632378
[TBL] [Abstract][Full Text] [Related]
18. The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation.
Fleeman N; McLeod C; Bagust A; Beale S; Boland A; Dundar Y; Jorgensen A; Payne K; Pirmohamed M; Pushpakom S; Walley T; de Warren-Penny P; Dickson R
Health Technol Assess; 2010 Jan; 14(3):1-157, iii. PubMed ID: 20031087
[TBL] [Abstract][Full Text] [Related]
19. The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder.
Höfer P; Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Konstantinidis A; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
Eur Arch Psychiatry Clin Neurosci; 2013 Aug; 263(5):385-91. PubMed ID: 23081704
[TBL] [Abstract][Full Text] [Related]
20. Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine.
McAlpine DE; Biernacka JM; Mrazek DA; O'Kane DJ; Stevens SR; Langman LJ; Courson VL; Bhagia J; Moyer TP
Ther Drug Monit; 2011 Feb; 33(1):14-20. PubMed ID: 21099743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
